Neural Regeneration Research

Article	Citations
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	320
Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	281
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	189
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	140
Functions of nuclear factor Y in nervous system development, function and health	116
The role of miRNA in retinal ganglion cell health and disease	105
Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	99
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	87
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	87
Protocadherin gamma C3: a new player in regulating vascular barrier function	68
Potential common pathogenesis of several neurodegenerative diseases	67
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	67
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	63
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	59
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	57
Retraction: Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy	56
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	54
Delayed microglial depletion protects against white matter injury following neonatal cerebral hemorrhage in mice	53
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	52
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	52
The intrinsic excitability of and autophagy protein expression levels in dentate gyrus ensembles regulate fear generalization	51
Telomere length as a predictive marker for long-term cognitive function in a mouse model of subarachnoid hemorrhage	51
Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation	51
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	50
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	50

Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice	48
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	48
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	48
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	47
Transcription factors promote neural regeneration after spinal cord injury	47
Axonal protein synthesis in central nervous system regeneration: is building an axon a local matter?	46
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	46
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	46
Could inorganic polyphosphate be a valid target against neuronal senescence?	45
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	45
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	45
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	45
Glymphatic imaging and modulation of the optic nerve	44
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	43
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	42
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	41
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: Targeting brain metabolic and vascular restoration	41
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	41
Stepping up after spinal cord injury: negotiating an obstacle during walking	41
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	41
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	41
Neuromodulation techniques for modulating cognitive function: Enhancing stimulation precision and intervention effects	41
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	41
NECAB family of neuronal calcium-binding proteins in health and disease	40
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	39
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	39
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	39
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	39
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	38
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	38
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	38
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	38
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	37
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	37
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	37
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	36
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	36
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	36
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	35
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	35
Amyloid-beta and tau protein beyond Alzheimer’s disease	35
Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	34
Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury	34
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	34
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	34
Functional near-infrared spectroscopy in non-invasive neuromodulation	34
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	34
Role of copper chelating agents: between old applications and new perspectives in neuroscience	34
Brain ischemia as a bridge to Alzheimer’s disease	33
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	33

Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington's disease	33
New aspects of a small GTPase RAB35 in brain development and function	33
Utility of droplet digital polymerase chain reaction for studying somatic mosaicism: brain malformations and beyond	32
Endorepellin downregulation promotes angiogenesis after experimental traumatic brain injury	32
Insights from an academic endeavor into central nervous system drug discovery	32
Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis	32
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease	32
NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression	31
Premature axon-oligodendrocyte interaction contributes to stalling of experimental axon regeneration after injury to the white matter	31
Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration	31
Amyotrophic lateral sclerosis disease burden: doing better at getting better	31
Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes	31
Effects of C2 hemisection on respiratory and cardiovascular functions in rats	30
Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery	30
New insights into the role of the endoplasmic reticulum in microglia	30
Optogenetics stimulates nerve reorganization in the contralesional anterolateral primary motor cortex in a mouse model of ischemic stroke	30
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease	30
Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease	30
Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury	29
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?	29
Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma	29
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer’s disease	29
Exercise training promotes nerve cell repair and regeneration after spinal cord injury	29
Dysfunction of synaptic endocytic trafficking in Parkinson’s disease	29
Exacerbation of neuronal senescence after spinal cord injury: Role of the macrophage-derived transforming growth factor-β1-SMAD2 signaling axis	29
The secondary injury cascade after spinal cord injury: an analysis of local cytokine/chemokine regulation	28
Modulation of p75 neurotrophin receptor mitigates brain damage following ischemic stroke in mice	28
Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases	28
Ruxolitinib attenuates secondary injury after traumatic spinal cord injury	28
On the functions of astrocyte-mediated neuronal slow inward currents	28
Biochanin A attenuates spinal cord injury in rats during early stages by inhibiting oxidative stress and inflammasome activation	28
Optical tissue clearing enables rapid, precise and comprehensive assessment of three-dimensional morphology in experimental nerve regeneration research	28
Retraction: Ultrasound guided neural stem cell transplantation through the lateral ventricle for treatment of cerebral palsy in children	28
Prediction of cell-cell communication patterns of dorsal root ganglion cells: single-cell RNA sequencing data analysis	27
Neuroprotection provided by polyphenols and flavonoids in photoreceptor degenerative diseases	27
Regulatory role of neuronal guidance proteins in spinal cord injury	27
Amyloid degradation mechanisms and potential synergistic effects	27
Converging assemblies: A putative building block for brain function and for interfacing with the brain	27
Dynamic regulation of the developmental establishment of the adult hippocampal neural stem cell pool	27
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease	27
Status of precision medicine approaches to traumatic brain injury	27
Therapeutic effects of low-intensity transcranial focused ultrasound stimulation on ischemic stroke in rats: An in vivo evaluation using electrical impedance tomography	27
Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke	26
Extracellular vesicles: multiple signaling capabilities and translation into promising therapeutic targets to promote neuronal plasticity	26
The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review	26
Role of calcium homeostasis in retinal ganglion cell degeneration	26
Exploring the novel role of oligodendrocyte precursor cells in phagocytosis: beyond myelinogenesis	26
Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junction	26
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease	26
M2 macrophages mediate fibrotic scar formation in the early stages after cerebral ischemia in rats	26
Targeting muscle to treat Charcot-Marie-Tooth disease	26
A core scientific problem in the treatment of central nervous system diseases: newborn neurons	26
Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke	26
Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury	26
Unraveling the role of ufmylation in the brain	26
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier	25
Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery	25
A Drosophila perspective on retina functions and dysfunctions	25
microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury	25
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease	25
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions	25
Commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”	25
Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis	24
Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway	24
Secretase inhibition in Alzheimer’s therapeutics reveals functional roles of amyloid-beta42	24
Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming	24
Making bridges between preclinical and clinical insights into age-related cognitive decline	24
Heterogeneity of mature oligodendrocytes in the central nervous system	24
New insights on the role of chondroitin sulfate proteoglycans in neural stem cell–mediated repair in spinal cord injury	24
Role of microtubule dynamics in Wallerian degeneration and nerve regeneration after peripheral nerve injury	24
Semaphorin7A: its role in the control of serotonergic circuits and functional recovery following spinal cord injury	24
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease	24
Letter from the Editor-in-Chief	24
Neuron-fibrous scaffold interfaces in the peripheral nervous system: a perspective on the structural requirements	24
Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury	24
Biomaterial-based strategies: a new era in spinal cord injury treatment	24
Implication of gut microbiome in age-related macular degeneration	24
Neuronal autosis: the self-destructive side of autophagy involved in hypoxic-ischemic neuronal death	24
Tau’s function and dysfunction in the brain	23
Artificial nerve graft constructed by coculture of activated Schwann cells and human hair keratin for repair of peripheral nerve defects	23

Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury	23
Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?	23
Schwann cell extracellular vesicles: judging a book by its cover	23
Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, n	23
Two become one: combination of two risk factors in a new glaucoma animal model	23
Carboplatin restores neuronal toxicity in FUS-linked amyotrophic lateral sclerosis	23
Bioactive material promotes long-distance regeneration of optic nerve to restore visual functions	23
Matrin-3 dysfunction in myopathy and motor neuron degeneration	23
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	23
Neuronal chemokines: new insights into neuronal communication after injury	23
Graphene oxide-composited chitosan scaffold contributes to functional recovery of injured spinal cord in rats	23
Current progress of mitochondrial therapy for neural regeneration	22
Multiple sclerosis drug repurposing for neuroregeneration	22
Stiffness-tunable biomaterials provide a good extracellular matrix environment for axon growth and regeneration	22
Knockout of Sirt2 alleviates traumatic brain injury in mice	22
Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer’s disease	22
Complement activation kindles the transition of acute post-traumatic brain injury to a chronic inflammatory disease	22
Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation	22
Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson’s disease	22
Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms	22
Brain-derived cell-free DNA	22
Effects of quercetin and its derivatives in in vivo models of neuroinflammation: a systematic review and meta-analysis	22
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles	22
Clues from a missense mutation of the adenosine A1 receptor gene associated with early-onset Parkinson’s disease	22
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database	22
5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis	22
Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina	22
Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation	22
Effects of delayed repair of peripheral nerve injury on the spatial distribution of motor endplates in target muscle	21
Transcranial photobiomodulation for the brain: a wide range of clinical applications	21
Metformin remodels the myelin landscape	21
Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease	21
Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy	21
Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease	21
Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury	21
The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease	21
Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis	21
The critical role of the endolysosomal system in cerebral ischemia	21
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders	21
Blood-brain barrier pathology in cerebral small vessel disease	21
Interconnections between diabetic corneal neuropathy and diabetic retinopathy: diagnostic and therapeutic implications	21
Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis	21
Neural and Müller glial adaptation of the retina to photoreceptor degeneration	21
Transcranial electrical stimulation in neurological disease	21
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?	21
Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration	21
Delayed activation of leg somatotopic fibers of an injured corticospinal tract in a patient with cerebral infarction	21
Exploring the synergy of the eye-brain connection: neuromodulation approaches for neurodegenerative disorders through transcorneal electrical stimulation	21
Actin(g) toward a revised understanding of the role of cytoskeletal dynamics in neuronal bioenergetics	21
Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration	20
Accelerating peripheral nerve regeneration using electrical stimulation of selected power spectral densities	20
Optogenetic neuroregeneration	20
Gut microbiota neurotransmitters: influence on risk and outcome of ischemic stroke	20
Remaking a connection: molecular players involved in post-injury synapse formation	20
Sex differences in Alzheimer’s disease: an urgent research venue to follow	20
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?	20
Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?	20
Stable isotope labeling-mass spectrometry as a new approach to determine remyelination	20
Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina	20
Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy	20
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies	20
Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall	20
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve	20
The new wave of p75 neurotrophin receptor targeted therapies	20
(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer’s disease transgenic mice	20
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models	19
Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease	19
Astrocyte evolution and human specificity	19
Renin-angiotensin system in the central nervous system: focus on Huntington’s disease	19
How physical and motor training affect cognitive performance: lessons from an inflammatory molecule	19
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?	19
Iron-handling solute carrier SLC22A17 as a blood–brain barrier target after stroke	19
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection	19
Blockade of Rho-associated kinase prevents inhibition of axon regeneration of peripheral nerves induced by anti-ganglioside antibodies	19
Striatum-specific mechanisms regulate neuronal cell cycle re-entry: the choice between life and death	19
Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease	19
Beyond wrecking a wall: revisiting the concept of blood–brain barrier breakdown in ischemic stroke	19
MET receptor tyrosine kinase promotes the generation of functional synapses in adult cortical circuits	19
Neuron-neuron attraction shapes morphology and activity of tissue engineered brain constructs	19
Can foods influence the onset and progress of neurodegenerative diseases?	19
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration	19
Fibrinogen’s potential role in connecting cerebrovascular abnormalities with glymphatic dysfunction in Alzheimer’s disease	19
A novel viewpoint in glaucoma therapeutics: enriched environment	19
Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease	19
Ischemic accumulation of succinate induces Cdc42 succinylation and inhibits neural stem cell proliferation after cerebral ischemia/reperfusion	18
M1-type microglia can induce astrocytes to deposit chondroitin sulfate proteoglycan after spinal cord injury	18
Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms	18
Extracellular vesicles for neural regeneration after spinal cord injury	18
Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure	18
Taurine: a promising nutraceutic in the prevention of retinal degeneration	18
From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson’s disease?	18
Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies	18
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence	18
Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury	18
Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and aging	18